Mitochondrial dynamics
|
|
|
|
|
Klotho |
Downregulator of DRP1 |
Alleviated mitochondrial fission and apoptosis |
In vivo |
[194] |
Luteolin |
Dephosphorylation of Drp1 Ser616
|
Inhibited mitochondrial fission and oxidative stress |
In vitro/in vivo |
[195] |
miRNA-532-3p |
Targeting apoptosis repressor with caspase recruitment domain |
Attenuated cardiomyocyte mitochondrial fission and apoptosis |
In vivo |
[107] |
Shenmai injection |
AMPK & PI3K/Akt/GSK-3β signaling pathway |
Alleviated mitochondrial fragmentation and oxidative stress |
In vitro/in vivo |
[103] |
Resveratrol |
Activator of Mfn-1 and -2 |
Prevented left ventricular (LV) remodeling and reduced mitochondrial fragmentation |
In vivo |
[196] |
LCZ696 |
Angiotensin receptor-neprilysin inhibitor (ARNi) |
Attenuated Drp1-mediated mitochondrial dysfunction |
In vitro/in vivo |
[197] |
Mdivi-1 |
Mitochondrial division inhibitor |
Inhibited mitochondrial fission |
In vitro/in vivo |
[98] |
Melatonin |
PGC1-α and SIRT1 modulator |
Decreased cell death and mitochondrial fission |
In vitro/in vivo |
[198] |
Ciclosporin A |
Inhibitor of mitochondrial membrane potential dissipation |
Attenuated mitochondrial fragmentation and partially restored mitochondrial bioenergetics |
In vivo |
[100] |
Honokiol |
Activator of Sirtuin-3 |
Promoted mitochondrial fusion |
In vitro/in vivo |
[199] |
Metformin |
Activator of AMPK |
Improved mitochondrial dynamics balance, biogenesis, and bioenergetics |
In vitro/in vivo |
[200, 201] |
Mitophagy
|
|
|
|
|
Heme oxygenase-1 |
A novel cardioprotective inducible enzyme |
Rescued the changes in mitophagy mediators PINK1 and parkin |
In vivo |
[135] |
Donepezil |
Acetylcholinesterase inhibitor |
Attenuated mitophagy, autophagy, and cardiomyocyte death |
In vivo |
[202] |
Liensinine |
A novel mitophagy inhibitor |
Inhibited mitophagy and mitochondrial fragmentation |
In vivo |
[57] |
Oseltamivir |
Neuraminidase1 inhibitor |
Inhibited the expression of Drp1 and PINK1 stabilization on mitochondria, attenuating excessive mitochondrial fission and mitophagy |
In vivo |
[203] |
miRNA-22 knockout |
SIRT-1/PGC-1α pathway |
Alleviated mitophagy and mitochondrial biogenesis |
In vitro/in vivo |
[131] |
Mitochondrial biogenesis
|
|
|
|
|
CO/HO |
Activator of Akt1/PKB and guanylate cyclase |
Promoted mitochondrial biogenesis and alleviated apoptosis |
In vitro/in vivo |
[204] |
Kirenol |
Activator of PI3K/AKT and Nrf2 pathway |
Rescued mitochondrial biogenesis and suppressed caspase-dependent apoptosis |
In vitro |
[205] |
Nerolidol |
Activator of Nrf2/MAPK signaling pathway |
Mitigated oxidative stress, inflammation, and apoptosis |
In vivo |
[206] |
Cyclovirobuxine D |
Activator of PGC-1α/Nrf1 signaling pathway |
Suppressed oxidative damage and mitochondrial biogenesis |
In vivo |
[207] |
Metallothionein |
Activator of PGC-1α/TFAM axis |
Preserved mitochondrial biogenesis and MnSOD expression |
In vivo |
[208] |
Yellow wine polyphenolic compounds (YWPC) |
Nrf2/TGF-β/smad3 pathway |
Mitigated oxidative stress, inflammatory response, and cardiac apoptosis |
In vivo |
[209] |
Cannabidiol |
Nonpsychoactive constituent of marijuana |
Rescued the Dox-induced cardiac mitochondrial function and biogenesis impairment |
In vivo |
[210] |